Peer-reviewed publications
Download the pieces below to access engaging summaries of peer-reviewed publications on ZOLGENSMA trials, safety data, and data from clinical practice. You may access the full article within each reprint.
Before treatment
Refer patients for treatment
To locate a treatment center that can administer ZOLGENSMA: Email treatments@curesma.org or contact the MDA Resource Center
at 1-833-ASK-MDA1 or resourcecenter@mdausa.org
Novartis Gene Therapies is offering the Novartis Gene Therapies Laboratory Program to assist with genetic and anti-AAV9 antibody testing. For more information, please contact your Novartis Gene Therapies Regional Account Associate Director or call the OneGene Program®
at 1-855-441-GENE (4363)
ZOLGENSMA Prescription and Patient Consent Forms
DOWNLOADPatient and caregiver support
Get support for you, your patients, and their families through the OneGene Program®
Patient advocacy groups
Patient advocacy organizations and other disease foundations can help caregivers and families contend with a new diagnosis, learn about SMA, and build meaningful connections.
Learn more about advocacy groups that support and educate families living with SMA at Novartis.com.